These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25693865)

  • 1. Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
    Chen R; Wang J; Zhang Y; Tang S; Zhan S
    Arch Toxicol; 2015 Jun; 89(6):883-97. PubMed ID: 25693865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
    Singla N; Gupta D; Birbian N; Singh J
    Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis.
    Lee SW; Chung LS; Huang HH; Chuang TY; Liou YH; Wu LS
    Int J Tuberc Lung Dis; 2010 May; 14(5):622-6. PubMed ID: 20392357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of isoniazid-induced hepatotoxicity.
    Perwitasari DA; Atthobari J; Wilffert B
    Drug Metab Rev; 2015 May; 47(2):222-8. PubMed ID: 26095714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.
    Sun Q; Liu HP; Zheng RJ; Wang P; Liu ZB; Sha W; Xiao HP
    Clin Drug Investig; 2017 Dec; 37(12):1125-1136. PubMed ID: 28900877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.
    Ji GY; Wang Y; Wu SQ; Liu QQ; Wu JC; Zhang MM; Sandford AJ; He JQ
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity.
    Chamorro JG; Castagnino JP; Aidar O; Musella RM; Frías A; Visca M; Nogueras M; Costa L; Perez A; Caradonna F; de Larrañaga GF
    Pharmacogenet Genomics; 2017 Oct; 27(10):363-371. PubMed ID: 28799976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity.
    Wu S; Wang YJ; Tang X; Wang Y; Wu J; Ji G; Zhang M; Chen G; Liu Q; Sandford AJ; He JQ
    PLoS One; 2016; 11(6):e0157478. PubMed ID: 27281183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UGT1A1 polymorphisms associated with risk of induced liver disorders by anti-tuberculosis medications.
    Chang JC; Liu EH; Lee CN; Lin YC; Yu MC; Bai KJ; Chen HY
    Int J Tuberc Lung Dis; 2012; 16(3):376-8. PubMed ID: 22230213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
    Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
    Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population.
    Lu L; Tao B; Wei H; Chen H; He X; Pan H; Yang M; Yi H; Tang S
    J Gene Med; 2019 Jun; 21(6):e3096. PubMed ID: 31066138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients.
    Nanashima K; Mawatari T; Tahara N; Higuchi N; Nakaura A; Inamine T; Kondo S; Yanagihara K; Fukushima K; Suyama N; Kohno S; Tsukamoto K
    Tuberculosis (Edinb); 2012 May; 92(3):253-9. PubMed ID: 22341855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs.
    Chamorro JG; Castagnino JP; Musella RM; Nogueras M; Aranda FM; Frías A; Visca M; Aidar O; Perés S; de Larrañaga GF
    J Gastroenterol Hepatol; 2013 Feb; 28(2):323-8. PubMed ID: 23190413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.
    Zhu J; Liu W; Zhang M; Lu L; Pan H; He X; Wang N; Yang M; Yi H; Tang S
    J Clin Pharm Ther; 2021 Oct; 46(5):1288-1294. PubMed ID: 34046917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence and outcome of anti-tuberculosis drug-induced hepatotoxicity in tuberculosis inpatients].
    Chen SX; Zhou L; Chen YZ; Pan HQ; Tang SW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):930-4. PubMed ID: 27453099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antituberculosis drug-induced hepatitis: risk factors, prevention and management.
    Hussain Z; Kar P; Husain SA
    Indian J Exp Biol; 2003 Nov; 41(11):1226-32. PubMed ID: 15332488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method for identifying causal genes of schizophrenia and anti-tuberculosis drug-induced hepatotoxicity.
    Huang T; Liu CL; Li LL; Cai MH; Chen WZ; Xu YF; O'Reilly PF; Cai L; He L
    Sci Rep; 2016 Sep; 6():32571. PubMed ID: 27580934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis.
    Sheng YJ; Wu G; He HY; Chen W; Zou YS; Li Q; Zhong L; Huang YM; Deng CL
    Infect Genet Evol; 2014 Jun; 24():34-40. PubMed ID: 24607341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity.
    Wang N; Guo S; Liu H; Ding Y; Yao R; Liu Z; Zhu H; Chen X; Yang X; Chen X; Lu Y
    Xenobiotica; 2022 May; 52(5):520-526. PubMed ID: 35723590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced liver injury: insights from genetic studies.
    Andrade RJ; Robles M; Ulzurrun E; Lucena MI
    Pharmacogenomics; 2009 Sep; 10(9):1467-87. PubMed ID: 19761370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.